Breaking News
-
Diagnostics | Neurological
Coming Soon: A Blood Test for Alzheimer's?
Recently, new biomarkers and assays have moved a reliable blood test closer to the clinic.American Chemical Society 01.18.19
-
Diagnostics
New Combination Blood Test May Catch Pancreatic Cancer Sooner
Simple blood test combined with existing test detects nearly 70 percent of pancreatic cancers with a less than 5 percent false-positive rate.Van Andel Research Institute 01.18.19
-
Diagnostics | Software & IT
FDA Clears EBM Technologies' Remote Diagnostic Reading of Radiological Images
Vendor-neutral, iPad Pro-based Rad@ system untethers radiologists from fixed workstations.Business Wire 01.18.19
-
Cardiovascular
JenaValve Technology Receives FDA Approval for Expanding its IDE Feasibility Studies
Trials to examine efficacy of treatment with Pericardial TAVR System with the Everdur transcatheter heart valve and Coronatix Transfemoral Delivery Catheter.Business Wire 01.18.19
-
IsoRay Names New Chief Financial Officer
Latest hire has more than 25 years of finance and accounting experience.Globe Newswire 01.18.19
-
First Patient Implanted With Implandata’s Eye Pressure Sensor for Continual Glaucoma Monitoring
The company's ARGOS-SC01 study is expected to conclude early next year.B3C Newswire 01.18.19
-
Materials
Bally Ribbon Mills Receives ISO 13485:2016 Certification
Recertification reflects commitment to supplying highest quality medical products.Bally Ribbon Mills 01.17.19
-
Outset Medical Names New Members of Leadership Team
Dr. Michael Aragon and Stacey Porter bring wealth of clinical and organizational expertise during time of company growth.Business Wire 01.17.19
-
Philips Launches Azurion with FlexArm for Image-Guided Therapy
Gantry breakthrough on industry-leading Azurion platform opens up new imaging and patient positioning opportunities to enhance care.Philips 01.17.19
-
Materials
Scientists Develop Self-Dissolvable Antibacterial Bandages
The biocompatible dressing material is able to act locally on the focus of inflammation.PR Newswire 01.17.19
-
Patient Monitoring | Software & IT
FDA Clears MIM Software's Molecular Radiotherapy Dosimetry
MIM SurePlan MRT allows for personalized dosimetry measurements.PR Newswire 01.17.19
-
Cardiovascular | Digital Health | Patient Monitoring
J&J, Apple Seek to Improve AFib Outcomes
Companies to collaborate to assess impact of wearable technology on earlier detection of AFib, improved diagnosis, and patient outcomes.Johnson & Johnson 01.17.19
-
Visioneering Technologies Appoints Vice President of Professional Services and Clinical Science
New executive brings depth and breadth of vision care expertise to the company as it expands globally.Business Wire 01.17.19
-
Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix
Company also launches its FDA-approved Excellagen, a proprietary patented wound care product.Business Wire 01.17.19
-
Tubing & Extrusion
Accu-Tube Launches Rebranding and Improvements
Initiative includes new logo, colors, and website for 45th anniversary, as well as a number of staff additions.Accu-Tube LLC 01.17.19
-
InspireMD Receives Australian Regulatory Approval of CGuard Embolic Prevention System
Company is immediately launching the product with its local distribution partner.Globe Newswire 01.17.19
-
Digital Health | Software & IT
Galen Data Awarded ISO 13485:2016
Certification positions company’s cloud-based connected medical platform solution for growth.Galen Data 01.16.19
-
Cardiovascular | Surgical
Sugary Stent Eases Suturing of Blood Vessels
3D-printed design ups speed, precision of surgical procedure.University of Nebraska - Lincoln 01.16.19
-
Materials
Biocoat Inc. Acquired by 1315 Capital
Specialty manufacturer of hydrophilic biomaterial coatings for medical devices has been acquired by healthcare growth investment firm.PR Newswire 01.16.19
-
Cardiovascular | Surgical
Abbott to Acquire Cephea Valve Technologies
Acquisition to further bolster Abbott's position in therapies for mitral valve disease, the most common type of heart valve ailment.Abbott Laboratories 01.16.19
